Technetium (99mTc) nofetumomab merpentan

From Self-sufficiency
Jump to: navigation, search
Technetium (99mTc) nofetumomab merpentan
File:Technetium-99m nofetumomab merpentan skeletal.svg
Monoclonal antibody
Type Fab fragment
Source Template:Infobox drug/mab source
Pharmacokinetic data
Biological half-life 10.5 hours
Excretion renal (64%)
Identifiers
CAS Number 165942-79-0
ATC code none
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Technetium (99mTc) nofetumomab merpentan (trade name Verluma) is a mouse monoclonal antibody used in the diagnosis of lung cancer[1], gastrointestinal, breast, ovary, pancreas, kidney, cervix, and bladder carcinoma[2]. The antibody itself, nofetumomab, is attached to the chelator merpentan, which links it to the radioisotope technetium-99m (99mTc).[3]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


  1. Straka, MR; Joyce, JM; Myers, DT (2000). "Tc-99m nofetumomab merpentan complements an equivocal bone scan for detecting skeletal metastatic disease from lung cancer". Clinical nuclear medicine. 25 (1): 54–5. PMID 10634533. 
  2. Breitz, HB; Tyler, A; Bjorn, MJ; Lesley, T; Weiden, PL (1997). "Clinical experience with Tc-99m nofetumomab merpentan (Verluma) radioimmunoscintigraphy". Clinical nuclear medicine. 22 (9): 615–20. PMID 9298295. 
  3. WHO Drug Information